Trials / Completed
CompletedNCT02312232
Pharmacokinetic Study in Healthy Males
Pharmacokinetics of Levodopa, Carbidopa, 3-OMD and ODM-104 After Repeated Doses of Different Formulations: an Open, Randomised, Multicentre Study With Crossover Design in Healthy Males
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the pharmacokinetics of levodopa, carbidopa, 3-OMD and ODM-104 after repeated doses of 3 levodopa formulations given in combination with carbidopa and ODM-104.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levodopa, carbidopa, ODM-104 |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-12-09
- Last updated
- 2015-02-18
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT02312232. Inclusion in this directory is not an endorsement.